AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 281: H566-H572, 2001;
0363-6135/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kohzuki, H.
Right arrow Articles by Takaki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohzuki, H.
Right arrow Articles by Takaki, M.
Vol. 281, Issue 2, H566-H572, August 2001

Sustained high O2 use for Ca2+ handling in rat ventricular slices under decreased free shortening after ryanodine

Hisaharu Kohzuki, Hiromi Misawa, Susumu Sakata, Yoshimi Ohga, and Miyako Takaki

Department of Physiology II, Nara Medical University, Kashihara, Nara 634-8521, Japan


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

We hypothesized that O2 wasting of Ca2+ handling in the excitation-contraction coupling in ryanodine-treated failing hearts might derive from an increased external Ca2+ extrusion via Na+/Ca2+ exchanger and futile Ca2+ cycling via sarcoplasmic reticulum (SR) Ca2+-ATPase. We tested this hypothesis by mechanoenergetic studies using rat left ventricular slices. After the slices were treated with ryanodine (0.1 µM), 1-Hz free shortening significantly decreased by 78-85%, whereas the observed O2 consumption (VO2) required for total Ca2+ handling, increased from 0.79 to 1.13 ml O2 · min-1 · 100 g LV-1 (155.6% of control). We reconfirmed that cyclopiazonic acid (10 µM), a blocker of SR Ca2+-ATPase, decreased VO2 by 75-80% in normal slices. However, 100 µM of cyclopiazonic acid was needed to inhibit the VO2 by 80% after ryanodine treatment. Blockade of a sarcolemmal Na+/Ca2+ exchanger by KB-R7943 (10 µM) significantly decreased VO2 by 45% after ryanodine treatment without significant effects on normal slices. Our results indicated that the VO2 increase following ryanodine treatment was derived from a net change of an increased external Ca2+ extrusion via Na+/Ca2+ exchanger and futile Ca2+ cycling via SR Ca2+-ATPase.

excitation-contraction coupling; sarcoplasmic reticulum Ca2+-ATPase; cyclopiazonic acid; recirculation fraction; KB-R7943; sarcolemmal Na+/Ca2+ exchanger


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

IT IS WELL KNOWN THAT alterations in intracellular Ca2+ handling of myocardium are closely associated with pathophysiological states, such as ischemia, acidosis, and stunning (13, 14, 23). Abnormalities in cardiac contractile activity induced during such pathological states are explained on the basis of changes in Ca2+ handling via sarcoplasmic reticulum (SR) (27) because SR plays a pivotal role in regulating the intracellular [Ca2+].

Takasago et al. (34) reported that the ryanodine-treated heart, as a failing heart model, decreased left ventricular contractility by one-half without decreasing the energy expenditure used for Ca2+ handling. The disproportionately high excitation-contraction (E-C) coupling rate of O2 consumption (VO2) relative to the contractility means O2 wasting for the contractility (12-14, 23, 27, 29, 33). We hypothesized that O2 wasting for Ca2+ handling in the E-C coupling in ryanodine-treated failing whole hearts might derive from a decreased internal Ca2+ recirculation fraction (RF) (16) and futile Ca2+ cycling via SR Ca2+-ATPase (16, 28). We tested this hypothesis by mechanoenergetic studies using rat left ventricular (LV) slices (18, 19, 32, 37) to directly evaluate the VO2 used for handling of the total Ca2+.

We recently instituted our specific measuring system for myocardial VO2 used for basal metabolism (basal VO2) and for handling of the total amount of Ca2+ in the E-C coupling under mechanically unloaded conditions by using 300-µm-thick rat LV myocardial slices (18, 19, 32, 37). We have successfully obtained the increment in VO2 by electrical field stimulation and have clarified the major origin of the VO2 (32, 37). First, VO2 was increased by the increase in extracellular [Ca2+] in a dose-dependent manner (37) but basal VO2 without field stimulation was not affected by the increase in extracellular [Ca2+] (37). Second, the slice motility was largely suppressed by using 5 mM of 2,3-butanedione monoxime (BDM) (32), a specific inhibitor of cross-bridge cycling; however, the increment in VO2 by field stimulation was not inhibited by 5 mM of BDM (37), which did not affect basal VO2 (37). These results suggest that VO2 does not consist of detectable energy consumption used for residual cross-bridge cycling, if any, under the free shortening of slices. Third, we observed that 10 µM cyclopiazonic acid (CPA), a specific blocker of the SR Ca2+-ATPase, reduced both the increment in VO2 and the motility by 70-80%, although it did not affect basal VO2 of quiescent slices (32). The similar extent of reduction in VO2 and the motility of rat myocardial slices strongly suggest that both reductions were caused by Ca2+ depletion in SR due to inhibition of SR Ca2+-ATPase. The underlying mechanisms for these observations were consistent with those reported by Janczewski and Lakatta (17) in intact rat cardiac myocytes. By taking our reports on energetics and motility of myocardial slices treated with BDM and CPA into consideration, we concluded that the VO2 by mechanically unloaded rat slices is mainly related to energy expenditure used for basal metabolism and for handling of total amount of Ca2+ in E-C coupling during 1-Hz free shortening.

In the present study, we planned to make pathophysiological myocardial slices mimick the O2 wasting failing whole heart model (34) after a long treatment with a low concentration of ryanodine. We then evaluated the origin of VO2 used for handling of the total Ca2+ in the pathophysiological slices by using a specific pharmacological tool of CPA to inhibit SR Ca2+-ATPase (18, 19, 32, 37). We also evaluated the contribution of external Ca2+ extrusion (4, 5, 11, 27) for VO2 used for handling of the total Ca2+ by using a specific blocker, KB-R7943 (10 µM), to inhibit Na+/Ca2+ exchange (20, 36).


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Left Ventricular Myocardial Slice Preparation

Forty-five adult male Wistar rats (Charles River Japan; Yokohama, Japan) weighing 350 ± 24 g were anesthetized with pentobarbital sodium (50 mg/kg ip). All of the experimental procedures were described previously in detail (18, 32, 37). Briefly, the whole heart was excised after perfusion with Tyrode solution at 12°C and was gassed with 100% O2 for 5 min. Each myocardial slice was cut into 300-µm-thick slices in parallel with the epicardium with a microslicer (model DTK-3000, Dosaka EM; Kyoto, Japan). We obtained 10-18 slices from each heart. The slices were stored in 18°C Tyrode solution for 30 min and then in 25°C Tyrode solution, and were gassed with 100% O2 for 30 min. The composition of Tyrode solution (in mmol/l) was 136.0 NaCl, 5.4 KCl, 1.0 MgCl2 · 6H2O, 0.33 NaH2PO4 · 2H2O, 0.9 CaCl2 · 2H2O, 10.0 glucose, and 5.0 HEPES, with pH corrected to 7.4 with NaOH at 30°C.

Image Analysis of Free Shortening of Myocardial Slices

Seventeen myocardial slices from 11 rats were used for image analysis of slice free shortening. One slice was placed in a 3-ml chamber for oximetry. The slice was gently superfused with Tyrode solution at ~5 ml/min for 10 or 20 min, while the magnetic stirrer was rotated. During image analysis, the airtight chamber was closed and the stirrer was turned off. Slice free shortening was evoked by 1-Hz field stimulation as described previously (32, 37).

We monitored and recorded the video image of slice free shortening for 3 min and nonstimulated slice image for 2 min with a microscopic video recording system (model SZH-131DA), a charge-coupled device color camera (model CS220, Olympus; Tokyo, Japan) and Victor cassette recorder model HR-D380. For quantitative analysis of slice free shortening, a video area analyzer (model C3153, Hamamatsu Photonics; Shizuoka, Japan) detected differences in light intensity between the slice and the surrounding field within a selected area (5 mm × 10 mm). The detected signals were then transmitted to a computer (model PC-98, NEC; Tokyo, Japan) for evaluation of free shortening as the relative changes in slice surface area (motility index) (32, 37). We used mean values of motility index from five free shortenings as motility index in each sampling time of 3, 33, 69, 105, 141, 159, and 171 s.

Assessment of VO2 of Myocardial Slices

A set of six myocardial slices on average was used to measure basal VO2 and mechanically unloaded myocardial VO2 during free shortening as a decreasing rate in [O2] of the solution in the oximetric chamber. VO2 of a set of slices was measured polarographically with an oxygen electrode (model 1T-125, Instech Labs; Plymouth Meeting, PA) as described previously (18, 32, 37). This oximetric system was calibrated at three different [O2] (in mg/l): 0 (5% Na2SO3 solution), 7.3 (Tyrode solution saturated with air), and 35.1 (Tyrode solution saturated with 100% O2) at 30°C in each experiment. Volume (in liters) of Tyrode in the chamber was measured at the end of the three time-repeated measurements (Fig. 1) for a set of slices. The mean ± SD per volume of Tyrode was 2.58 ± 0.06 ml (n = 65 measurements).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 1.   Experimental protocols to produce energy wasting state of rat myocardial slices under reduced free shortening by treatment with 0.1 µM ryanodine and evaluate the origin of the waste of O2 consumption (VO2) using a blocker of sarcoplasmic reticulum Ca2+-ATPase, cyclopiazonic acid (CPA; 10 and 100 µM), and a blocker of sarcolemmal Na+/Ca2+ exchanger, KB-R7943 (10 µM). Time scales indicate the first, second, and third measurements (open and striped boxes) and superfusion (horizontal thin line) of normal Tyrode (NT) with or without ryanodine, CPA, and KB-R7943. Three-minute 1-Hz field stimulation was inserted during the second long-term superfusion to gain a complete effect of ryanodine in protocols 1, 2, and 5. Comparison with different sets of slices was made to avoid an order effect of treatment (see METHODS).

We first examined the mean value of the background VO2 without myocardial slices in the Tyrode-filled chamber at the beginning and end (0.75 ± 0.19 mg O2/min, n = 65) of each measurement. We measured the wet weight of each set of slices (73.0 ± 11.7 mg, n = 65 sets of slices). We calculated VO2 of slices by subtracting the background VO2 (A; mg O2/min) from the measured VO2 (B; in mg O2/min) with myocardial slices. Myocardial VO2 (ml O2 · min-1 · 100 g LV-1) was calculated as [(B - A)/slice wet weight (in grams)] × volume of Tyrode solution in the chamber (in liters) × [22.4 (liters)/32 (gram)] × 100 g.

Experimental Procedure

Basal VO2 without stimulation of the quiescent slices was obtained during the first 2 min (open bars in Fig. 1). VO2 with 1-Hz stimulation of free-shortening slices was obtained during the next 3 min (striped bars in Fig. 1). VO2 used for handling of the total Ca2+ (Delta VO2) is obtained by subtracting basal VO2 from VO2 with 1-Hz stimulation. Basal VO2 and Delta VO2 were compared in two different ways, i.e., among the first, second, and third measurement of VO2 in the same set of slices, and among different set of slices under the comparable protocol (Fig. 1).

Experimental Protocol

We used six protocols (see also Fig. 1) for the following four studies.

Study 1: effect of ryanodine on slice free shortening. We determined the inhibitory effect of 0.1 µM ryanodine by comparing the motility index in normal Tyrode (NT) solution (see Fig. 1) in the third measurements in protocol 3 with that after ryanodine treatment in protocol 1 (Fig. 2). Eleven slices in protocol 1 and six slices in protocol 3 were used from 11 rats.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of ryanodine on time course of free shortening of rat myocardial slices evaluated by mean values of motility index (MI, in %) from 5 twitches. MI = 100 × (maximum area of slice image - minimum area of slice image)/maximum area of slice image during a single twitch. A: MI of slice treated with NT at first (open circle ), second (), and third (triangle ) measurements (protocol 3). B: MI of slice treated with NT (open circle ), 0.1 µM of ryanodine (), and NT after ryanodine treatment (black-triangle) in sequence (protocol 1). Values are means (SE was omitted for simplification). *P < 0.05, significant difference between the second measurement with ryanodine and the third measurement after ryanodine from 3 to 171 s of 1-Hz field stimulation. §P < 0.05, significant difference between the first measurement with NT and the second measurement with ryanodine from 105 to 171 s. #P< 0.05, significant difference of initial MI between the first measurement with NT and the second measurement with ryanodine.

Study 2: effect of ryanodine (0.1 µM) on basal VO2 and Delta VO2. We investigated the effect of ryanodine by comparing both VO2 forms after ryanodine treatment in protocol 1 with both of VO2 in protocol 3 (see Figs. 3 and 4).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Significantly high Delta VO2 [O2 consumption (VO2) obtained by subtracting basal VO2 from the VO2 with 1-Hz stimulation] after long-term ryanodine (Rya, 0.1 µM) treatment in rat myocardial slices. First through third Delta VO2 were repeatedly measured in the following order after superfusion with NT solution (open bar), ryanodine-containing Tyrode (solid bar), and NT (hatched bar) solutions. Each bar is mean ± SD. *Significant difference (P < 0.05).



View larger version (29K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of 10 and 100 µM cyclopiazonic acid (CPA), a sacroplasmic reticulum Ca2+-ATPase blocker, on Delta VO2 of rat myocardial slices without or after Rya (0.1 µM) treatment. Each bar is mean ± SD. *Significant difference (P < 0.05).

Study 3: effect of CPA on basal VO2 and Delta VO2. We investigated the effect of 10 µM CPA on both of VO2 after ryanodine by comparing (Fig. 1) both of VO2 after ryanodine treatment in protocol 2 with those in protocol 1 (7 sets of slices from 7 rats in each protocol). We also investigated the effect of 10 µM CPA on both basal VO2 and Delta VO2 in normal slices by comparing (Fig. 1) both basal VO2 and Delta VO2 in protocol 4 with that in protocol 3 (7 sets of slices from 7 rats in each protocol). We investigated the effect of 100 µM CPA on both basal VO2 and Delta VO2 after ryanodine in protocol 2 (8 sets of slices from 5 rats) compared with those in protocol 1 (Fig. 4).

Study 4: effects of KB-R7943 (10 µM) on basal VO2 and Delta VO2. We investigated the effect of KB-R7943 on both types of VO2 after ryanodine treatment by comparing (Fig. 1) both types of VO2 after ryanodine in protocol 5 with those in protocol 1 (6 sets of slices from 6 rats in each protocol) (see Fig. 5). We investigated the effect of KB-R7943 on both types of VO2 in normal slices by comparing (see Fig. 1) both types of VO2 in protocol 6 with those in protocol 3 (11 and 6 sets of slices from 9 rats in each protocol).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of KB-R7943 (KB-R, 10 µM), a blocker of sarcolemmal Na+/Ca2+ exchanger, on Delta VO2 of rat myocardial slices without or after Rya (0.1 µM) treatment. Each bar is mean ± SD. *Significant difference (P < 0.05).

Ryanodine (Wako; Osaka, Japan) was dissolved in distilled water, and the solution was further diluted with NT just before use. CPA (Sigma; St. Louis, MO) and KB-R7943 (Kanebo; Tokyo, Japan) were dissolved in dimethyl sulfoxide (DMSO), and the solution was further diluted with NT just before use (1.0-1.3% of DMSO final concentration).

Statistics

All data were means ± SD, except for the motility data, which were means ± SE. Multiple comparisons were performed by one-way and repeated-measures ANOVA and Bonferroni t-test. Student's unpaired t-test was used for the percent inhibition values obtained by CPA and KB-R7943 and the percent decrease of slice image between control and ryanodine treatment. In all statistical tests, P < 0.05 were considered statistically significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Free Shortening of Rat Myocardial Slice After Ryanodine Treatment

In protocol 3 (Fig. 2A), motility index values were fairly constant between 69 (0.54 ± 0.56%) and 141 s (0.48 ± 0.49%) during the first measurement in NT. Each motility index at the same time during the first, second, and the third measurements in NT was not significantly different among the three repeated measurements (P < 0.05). Although motility index at 3 s (initial free-shortening) was not significantly different among them (P < 0.05), these values were significantly higher than those at 33-171 s throughout the first to third measurements. However, motility index values later than 69 s did not decrease significantly during all three measurements.

In protocol 1 (see Fig. 2B), motility index values were fairly constant between 69 (0.63 ± 0.41%) and 141 s (0.59 ± 0.34%) during the first measurement in NT. Motility index at 105 s during the second measurement with ryanodine was 0.37 ± 0.18% and was significantly smaller than the corresponding value during the first measurement in NT. Motility index during the third measurement after ryanodine treatment were significantly different from those during the first and second measurements (P < 0.05). The value was also significantly decreased by 75% from corresponding values during the third measurement in NT in protocol 3 (see Fig. 2A) (P < 0.05). Motility index values at 3 s at the first, second, and third measurements in protocol 1 were significantly different among them (P < 0.05).

If the presently observed reduction of the motility index is due to the decrease of maximal area of slice image at each shortening, the slice after treatment of ryanodine or with treatment of CPA would cause the contracture. However, there were no significant difference in the maximal area of slice image at each shortening between the first measurement of NT and the third measurement after ryanodine treatment at 1 min of 1-Hz stimulation (P < 0.05). We also have observed no significant decrease of maximal area of slice treated with CPA (10 µM) during 1-Hz stimulation, although the data are not shown (32). Furthermore, the basal VO2 of the slice obtained without 1-Hz electrical stimulation did not increase after ryanodine treatment (protocol 1) or with CPA treatment (protocol 4), suggesting no slice contracture.

Basal VO2 and Delta VO2 After Ryanodine Treatment

Among protocols 1-6, basal VO2 values at first, second, and third measurements were not significantly different. Three-minute 1-Hz stimulation inserted during ryanodine treatment did not affect basal VO2 at the second measurement. Thus basal VO2 was unaffected during and after ryanodine treatment compared with that in NT. Mean basal VO2 values ranged between 1.94 and 2.44 ml O2 · min-1 · 100 g LV-1, corresponding to our previous values (15, 27, 33).

Each Delta VO2 at the second measurement during ryanodine treatment did not significantly increase from that at the first measurement in NT (protocols 1 and 2). However, Delta VO2 after ryanodine treatment (the third VO2) significantly increased from that at the first measurement in NT (protocol 1) (Fig. 3). Furthermore, Delta VO2 after ryanodine treatment at the third measurement in protocol 1 was higher than that at the third measurement in protocol 3, although not statistically significant (P = 0.06) (Fig. 4).

Effect of CPA on Basal VO2 and Delta VO2 After Ryanodine Treatment

In protocols 2 and 4, CPA (10 and 100 µM) did not affect basal VO2, irrespective of ryanodine treatment. On the other hand, CPA significantly decreased Delta VO2, from 0.86 to 0.16 ml O2 · min-1 · 100 g LV-1, by 80.1 ± 16.4% (means ± SD of the second VO2 in protocol 4). The third VO2 in different sets of slices in protocols 3 and 4 were compared, indicating that Delta VO2 were 0.84 ml O2 · min-1 · 100 g LV-1 with NT and 0.16 ml O2 · min-1 · 100 g LV-1 with CPA (see Fig. 4). The CPA-induced inhibition was 74.8 ± 22.6% of the third VO2 in NT in protocol 3. Therefore, without ryanodine treatment, the fraction of CPA-sensitive VO2 was 74.8-81.8%. However, the third VO2 in different sets of slices in protocols 1 and 2 were compared, indicating that Delta VO2 were 1.13 ml O2 · min-1 · 100 g LV-1 after ryanodine treatment and 0.69 ml O2 · min-1 · 100 g LV-1 after ryanodine treatment in the presence of CPA of 10 µM (Fig. 4). The effect of CPA was presented by an inhibition by only 41.2 ± 15.5% of the third VO2 in protocol 1. Thus the fraction of 10-µM CPA-sensitive Delta VO2 was significantly decreased after ryanodine treatment (P < 0.05). However, a high concentration (100 µM) of CPA largely decreased Delta VO2 to 0.29 ± 0.26 of ml O2 · min-1 · 100 g LV-1 (77% inhibition) (Fig. 4).

Effect of KB-R7943 on Basal VO2 and Delta VO2 With or Without Ryanodine Treatment

KB-R7943 (10 µM) did not affect basal VO2, irrespective of ryanodine treatment (see Fig. 5). KB-R7943 did not significantly decrease Delta VO2 (1.03 ± 0.41 vs. 0.90 ± 0.40 ml O2 · min-1 · 100 g LV-1) in normal slices without ryanodine treatment in protocol 6. The third VO2 in protocols 3 and 6 were compared, indicating that Delta VO2 were 0.98 ± 0.35 ml O2 · min-1 · 100 g LV-1 with NT and 0.90 ± 0.40 ml O2 · min-1 · 100 g LV-1 with KBR7943 (Fig. 5). The KB-R7943-induced inhibition was only 17.4 ± 41.4% of the third VO2 in protocol 3, indicating no significant decrease in Delta VO2 by KB-R7943 in normal slices.

The third VO2 in protocols 1 and 5 were compared, indicating that Delta VO2 were 1.25 ± 0.32 ml O2 · min-1 · 100 g LV-1 after ryanodine treatment and 0.70 ± 0.37 ml O2 · min-1 · 100 g LV-1 (P < 0.05) after ryanodine treatment with KB-R7943 (Fig. 5). The KB-R7943-induced inhibition was 44.9 ± 20.6% of the third VO2 in protocol 1, indicating KB-R7943-induced inhibition on Delta VO2 significantly increased after ryanodine treatment (P < 0.05).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

We successfully made pathophysiological O2 wasting rat myocardial slices by mimicking the O2 wasting failing whole heart model (16, 34) after a long treatment with a low concentration of ryanodine. The failing heart halved left ventricular contractility without decreasing VO2 used for Ca2+ handling (34). The disproportionately high E-C coupling VO2 relative to the contractility means O2 wasting for the contractility (12-14, 23, 27, 29, 33). In the present study, the effect of 0.1 µM of ryanodine was confirmed by the observation that long-term treatment with ryanodine abolished a "negative force staircase phenomenon" (8) or "Woodworth phenomenon" (6, 30) and decreased the initial free shortening in the rat myocardial slice. Delta VO2 of slices after ryanodine treatment increased from 0.79 to 1.13 ml O2 · min-1 · 100 g LV-1 by 55.6%. On the other hand, the motility index for free shortening was largely decreased by ~80% after ryanodine treatment. This may be due to futile Ca2+ cycling (11, 21, 27, 29) and/or a reduced Ca2+ content in the SR (7, 30) resulting from a Ca2+ leak (24, 35) during interstimulus interval (5, 25).

Effect of CPA on Basal VO2 and Delta VO2

We have already reported that the energy expenditure of myocardial slices during 1-Hz free shortening is composed of both VO2 used for total Ca2+ handling in E-C coupling, i.e., Delta VO2, and VO2 used for basal metabolism (basal VO2). However, it is not composed of the detectable VO2 used for the residual cross-bridge cycling under mechanically unloaded slices (32, 37). In the present study, neither ryanodine nor CPA treatment, even a much higher CPA concentration, affected basal VO2. Thus Delta VO2 is obtained by subtracting basal VO2 from VO2 of the stimulated slices as previously reported (32, 37).

The present results showing that CPA decreased the Delta VO2 used for total Ca2+ handling by ~80% in normal slices are consistent with our previous results showing that ~70% of VO2 used for total Ca2+ handling is derived from the SR Ca2+-ATPase (32). In normal rat hearts, 80% of Ca2+ was intracellular RF, i.e., the SR Ca2+-ATPase plays a main role in Ca2+ handling (1, 2, 5, 15, 32).

In muticellular preparations of rabbit papillary muscle or ventricular trabeculae, complete blockade of SR Ca2+-ATPase by CPA cannot be attained because the rapid cooling contractures to assess the SR Ca2+ load were not completely abolished by 100 µM of CPA. The remaining caffeine- and ryanodine-sensitive SR Ca2+ release must have occurred after CPA treatment (4). The discrepancy in CPA effects between this and our observation seems to be partly related to the difference of activation mechanism on Ca2+ release from SR.

Effect of CPA and KB-R7943 on Delta VO2 After Ryanodine Treatment

In cardiac muscle, SR Ca2+-ATPase activity is potently regulated by an inhibitory protein phospholamban. In its unphosphorylated state, phospholamban strongly attenuates SR Ca2+-ATPase activity. This inhibition is relieved through increases in [Ca2+] or through protein kinase A- or Ca2+/calmodulin-dependent protein kinase-mediated phosphorylation of phospholamban (3, 22). The activity of SR Ca2+-ATPase of myocardial slices after ryanodine treatment seems to be enhanced (3), because 100 µM of CPA was needed to decrease Delta VO2 to the similar extent by 10 µM of CPA in normal slices. Leaked Ca2+ from SR may increase the activity of SR Ca2+-ATPase, and consequently, the Delta VO2 would increase.

It has been reported (28) that the affinity of SR Ca2+-ATPase for CPA is dependent on the conformational state of the enzyme related to the Ca2+ binding. If the affinity of SR Ca2+-ATPase for CPA decreases after ryanodine treatment, much higher concentrations of 100 µM CPA are needed to inhibit the SR Ca2+-ATPase and thus VO2 in the ryanodine-treated slices. However, the other possibility, whether the L-type Ca2+ current is directly or secondarily depressed by higher concentration (100 µM) of CPA, could not be excluded, although the effect of CPA at higher concentration on L-type Ca2+ current is not well known (4, 26). Ryanodine also may interfere with interaction of CPA and the SR Ca2+-ATPase (9, 10).

Recently, KB-R7943, a novel inhibitor of the sarcolemmal Na+/Ca2+ exchanger, has been introduced (20, 36). The result showing no effect of KB-R7943 on the Delta VO2 in normal slices indicates that neither mode of sarcolemmal Na+/Ca2+ exchanger contributes to the Delta VO2 to the detectable extent. However, KB-R7943 decreased Delta VO2 by 44.9% compared with the increased Delta VO2 after ryanodine treatment. The result would suggest the increased external Ca2+ extrusion via sarcolemmal Na+/Ca2+ exchanger (27), regardless of its underlying mechanism (4, 5, 11). This suggestion is supported by previous reports (2, 16) showing the decrease in internal Ca2+ RF (indicated by the exponential decay beat constant) after ryanodine treatment. The increased external Ca2+ extrusion would result in the increase in VO2 used for total Ca2+ handling after ryanodine treatment, because the external Ca2+ extrusion consumes more energy via sarcolemmal Na+/Ca2+ exchanger and Na+-K+-ATPase system, having 1 Ca2+: 1 ATP stoichiometry, than that of the internal Ca2+ RF via SR Ca2+-ATPase, having 2 Ca2+:1 ATP stoichiometry (23, 27, 29, 32, 33).

The present results indicate that the increased VO2 used for total Ca2+ handling after ryanodine treatment is derived from a net change of futile Ca2+ cycling via SR Ca2+-ATPase and an increased (energetically more wasting) external Ca2+ extrusion. Furthermore, other energy-consuming processes such as sarcolemmal Ca2+- ATPase may contribute to VO2 used for total Ca2+ handling. Further study is required to clarify the origin of O2 wasting use due to the futile Ca2+ cycling via SR or sarcolemma.


    ACKNOWLEDGEMENTS

We thank Yukishige Akagi, of the Okayama Rail Road Model Shop, for generously custom-making our oximetric chamber system.


    FOOTNOTES

This study was supported in part by a Grant-in-Aid for Scientific Research (11470277) from the Ministry of Education, Science, Sports and Culture.

Address for reprint requests and other correspondence: H. Kohzuki, Dept. Physiology II, Nara Medical Univ., 840 Shijo-cho, Kashihara, Nara 634-8521, Japan (E-mail: hkohzuki{at}naramed-u.ac.jp).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 2 October 2000; accepted in final form 26 March 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Ásgrimsson, HJ, Wohlfart B, Brandt J, and Jóhannsson M. Effects of [Na+]o, [Ca2+]o and cyclopiazonic acid on decline of post-extrasystolic potentiation and twitch kinetics in guinea-pig and human myocardial preparations. Acta Physiol Scand 166: 195-201, 1999[Web of Science][Medline].

2.   Banijamali, HS, Gao WD, MacIntosh BR, and ter Keurs HEDJ Force-interval relations of twitches and cold contractures in rat cardiac trabeculae effect of ryanodine. Circ Res 69: 937-948, 1991[Abstract/Free Full Text].

3.   Bassani, RA, Mattiazzi A, and Bers DM. CaMKII is responsible for activity-dependent acceleration of relaxation in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 268: H703-H712, 1995[Abstract/Free Full Text].

4.   Baudet, S, Shaoulian R, and Bers DM. Effects of thapsigargin and cyclopiazonic acid on twitch force and sarcoplasmic reticulum Ca2+ content of rabbit ventricular muscle. Circ Res 73: 813-819, 1993[Abstract/Free Full Text].

5.   Bers, DM. Mechanisms contributing to the cardiac inotropic effect of Na pump inhibition and reduction of extracellular Na. J Gen Physiol 90: 479-504, 1987[Abstract/Free Full Text].

6.   Capogrossi, MC, Kort AA, Spurgen HA, and Lakatta EG. Single adult rabbit and rat cardiac myocytes retain the Ca2+- and species-dependent systolic and diastolic contractile properties of intact muscle. J Gen Physiol 88: 589-613, 1986[Abstract/Free Full Text].

7.   Endo, M, Tanaka M, and Ogawa Y. Calcium induced release of calcium from the sarcoplasmic reticulum of skinned skeletal muscle fibres. Nature 228: 34-36, 1970[Medline].

8.   Ezzaher, A, Bouanai Nel H, and Crozatier B. Force-frequency relations and response to ryanodine in failing rabbit hearts. Am J Physiol Heart Circ Physiol 263: H1710-H1715, 1992[Abstract/Free Full Text].

9.   Feher, JJ, Lee KN, and Wu QY. Ryanodine-sensitive, thapsigargin-insensitive calcium uptake in rat ventricle homogenates. Mol Cell Biochem 189: 9-17, 1998[Web of Science][Medline].

10.   Fortea, M-I, Soler F, and Fernandez-Belda F. Insight into the uncoupling mechanism of sarcoplasmic reticulum ATPase using the phosphorylating substrate UTP. J Biol Chem 275: 12521-12529, 2000[Abstract/Free Full Text].

11.   Ginsburg, KS, Weber CR, and Bers DM. Control of maximal sarcoplasmic reticulum Ca load in intact ferret ventricular myocytes. Effects of thapsigargin and isoproterenol. J Gen Physiol 111: 491-504, 1998[Abstract/Free Full Text].

12.   Goto, Y, Slinker BK, and LeWinter MM. Effects of amrinone and isoproterenol on mechanoenergetics of blood-perfused rabbit heart. Am J Physiol Heart Circ Physiol 262: H719-H727, 1992[Abstract/Free Full Text].

13.   Hata, K, Goto Y, Kawaguchi O, Takasago T, Saeki A, Nishioka T, and Suga H. Hypercapnic acidosis increases oxygen cost of contractility in the dog left ventricule. Am J Physiol Heart Circ Physiol 266: H730-H740, 1994[Abstract/Free Full Text].

14.   Hata, K, Takasago T, Saeki A, Nishioka T, and Goto Y. Stunned myocardium after rapid correction of acidosis. Increased oxygen cost of contractility and the role of the Na+-H+ exchange system. Circ Res 74: 794-805, 1994[Abstract/Free Full Text].

15.   Hata, Y, Sakamoto T, Hosogi S, Ohe T, Suga H, and Takaki M. Effects of thapsigargin and KCl on the O2 use of the excised blood-perfused rat heart. J Mol Cell Cardiol 30: 2137-2144, 1998[Web of Science][Medline].

16.   Hata, Y, Shimizu J, Hosogi S, Matsubara H, Araki J, Ohe T, Takaki M, Takasago T, Taylor TW, and Suga H. Ryanodine decreases internal Ca2+ recirculation fraction of the canine heart as studied by postextrasystolic transient alternans. Jpn J Physiol 47: 521-530, 1997[Web of Science][Medline].

17.   Janczewski, AM, and Lakatta EG. Thapsigargin inhibits Ca2+ uptake, and Ca2+ depletes sarcoplasmic reticulum in intact cardiac myocytes. Am J Physiol Heart Circ Physiol 265: H517-H522, 1993[Abstract/Free Full Text].

18.   Kohzuki, H, Misawa H, Sakata S, Ohga Y, Suga H, and Takaki M. Energy expenditure by Ba2+ contracture in rat ventricular slices derives from cross-bridge cycling. Am J Physiol Heart Circ Physiol 277: H74-H79, 1999[Abstract/Free Full Text].

19.   Kohzuki, H, Misawa H, Sakata S, and Takaki M. Barium contracture in rat ventricular slices and its energy expenditure: inhibitory effect of pretreatment with cyclopiazonic acid. In: Control and Diseases of Sodium Dependent Transport Proteins and Ion Channels, edited by Suketa Y, Carafori E, Lazdunski M, Mikoshiba K, Okada Y, and Wright EM.. Amsterdam: Elsevier, 2000, p. 439-440.

20.   Ladilov, Y, Haffner S, Balser-Schafer C, Maxeiner H, and Piper HM. Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na+/Ca2+ exchanger. Am J Physiol Heart Circ Physiol 276: H1868-H1876, 1999[Abstract/Free Full Text].

21.   Lewartowski, B, Rózycka M, and Janiak R. Effects of thapsigargin in normal and pretreated with ryanodine guinea pig cardiomyocytes. Am J Physiol Heart Circ Physiol 266: H1829-H1839, 1994[Abstract/Free Full Text].

22.   Odermatt, A, Kurzydlowski K, and MacLennan DH. The Vmax of the Ca2+-ATPase of cardiac sarcoplasmic reticulum (SERCA2a) is not altered by Ca2+/calmodulin-dependent phosphorylation or by interaction with phospholamban. J Biol Chem 271: 14206-14213, 1996[Abstract/Free Full Text].

23.   Ohgoshi, Y, Goto Y, Futaki S, Yaku H, Kawaguchi O, and Suga H. Increased oxygen cost of contractility in stunned myocardium of dog. Circ Res 69: 975-988, 1991[Abstract/Free Full Text].

24.   Oyamada, H, Iino M, and Endo M. Effects of ryanodine on the properties of Ca2+ release from the sarcoplasmic reticulum in skinned skeletal muscle fibres of the frog. J Physiol (Lond) 470: 335-348, 1993[Abstract/Free Full Text].

25.   Pery-Man, N, Chemla D, Coirault C, Suard I, Riou B, and Lecarpentier Y. A comparison of cyclopiazonic acid and ryanodine effects on cardiac muscle relaxation. Am J Physiol Heart Circ Physiol 265: H1364-H1372, 1993[Abstract/Free Full Text].

26.   Rigg, L, and Terrar DA. Possible role of calcium release from the sarcoplasmic reticulum in pacemaking in guinea-pig sino-atrial node. Exp Physiol 81: 877-880, 1996[Abstract].

27.   Shimizu, J, Araki J, Mizuno J, Lee S, Syuu Y, Hosogi S, Mohri S, Mikane T, Takaki M, Taylor TW, and Suga H. A new integrative method to quantify total Ca2+ handling and futile Ca2+ cycling in failing hearts. Am J Physiol Heart Circ Physiol 275: H2325-H2333, 1998[Abstract/Free Full Text].

28.   Soler, F, Plenge-Tellechea F, Fortea I, and Fernandez-Belda F. Cyclopiazonic acid effect on Ca2+-dependent conformational states of the sarcoplasmic reticulum ATPase. Implication for the enzyme turnover. Biochemistry 37: 4266-4274, 1998[Medline].

29.   Suga, H. Ventricular energetics. Physiol Rev 70: 247-277, 1990[Free Full Text].

30.   Sutko, JL, and Willerson JT. Ryanodine alteration of the contractile state of rat ventricular myocardium. Comparison with dog, cat, and rabbit ventricular tissues. Circ Res 46: 332-343, 1980[Free Full Text].

31.   Takahashi, S, Kato Y, Adachi M, Agata N, Tanaka H, and Shigenobu K. Effect of cyclopiazonic acid on rat myocardium: inhibition of calcium uptake into sarcoplasmic reticulum. J Pharmacol Exp Ther 272: 1095-1100, 1995[Abstract/Free Full Text].

32.   Takaki, M, Kohzuki H, Kawatani Y, Yoshida A, Ishidate H, and Suga H. Sarcoplasmic reticulum Ca2+ pump blockade decreases O2 use of unloaded contracting rat heart slices: thapsigargin and cyclopiazonic acid. J Mol Cell Cardiol 30: 649-659, 1998[Web of Science][Medline].

33.   Takaki, M, Matsubara H, Araki J, Zhao LY, Ito H, Yasuhara S, Fujii W, and Suga H. Mechanoenergetics of acute failing hearts characterized by oxygen costs of mechanical energy and contractility. In: New Horizons for Failing Heart Syndrome, edited by Sasayama S.. Tokyo: Springer-Verlag Tokyo, 1996, p. 133-164.

34.   Takasago, T, Goto Y, Kawaguchi O, Hata K, Saeki A, Nishioka T, and Suga H. Ryanodine wastes oxygen consumption for Ca2+ handling in the dog heart. A new pathological heart model. J Clin Invest 92: 823-830, 1993.

35.   Urthaler, F, Walker AA, Reeves RC, and Hefner LL. Effects of ryanodine on contractile performance on intact length-clamped papillary muscle. Circ Res 65: 1270-1282, 1989[Abstract/Free Full Text].

36.   Watano, T, Kimura J, Morita T, and Nakanishi H. A novel antagonist, No. 7943, of the Na+/Ca2+ exchanger current in guinea-pig cardiac ventricular cells. Br J Pharmacol 119: 555-563, 1996[Web of Science][Medline].

37.   Yasuhara, S, Takaki M, Kikuta A, Ito H, and Suga H. Myocardial VO2 of mechanically unloaded contraction of rat ventricular slices measured by a new approach. Am J Physiol Heart Circ Physiol 270: H1063-H1070, 1996[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 281(2):H566-H572
0363-6135/01 $5.00 Copyright © 2001 the American Physiological Society




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kohzuki, H.
Right arrow Articles by Takaki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohzuki, H.
Right arrow Articles by Takaki, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online